Dulaglutide Clinical Trials
3 recruitingDrug
Phase 32Phase 11Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Type 2 Diabetes
Eli Lilly and Company55 enrolled51 locationsNCT06739122
Recruiting
Phase 1
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company20 enrolled1 locationNCT07313813
Recruiting
Phase 2Phase 3
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Stroke, IschemicIntracranial Atherosclerosis
National University of Singapore130 enrolled1 locationNCT07282041